Patients had been diagnosed with either postoperative recurrence or metastatic NSCLC which were all adenocarcinoma, and all patients had ALK fusion gene-positive NSCLC without epidermal growth factor receptor mutations. This evidence concerns the gene ALK and adenocarcinoma.